Invention Grant
- Patent Title: Substituted quinazolines as kinase inhibitors
- Patent Title (中): 取代喹唑啉作为激酶抑制剂
-
Application No.: US14491929Application Date: 2014-09-19
-
Publication No.: US09359349B2Publication Date: 2016-06-07
- Inventor: Pingda Ren , Yi Liu , Troy Edward Wilson
- Applicant: Intellikine LLC
- Applicant Address: US CA La Jolla
- Assignee: INTELLIKINE LLC
- Current Assignee: INTELLIKINE LLC
- Current Assignee Address: US CA La Jolla
- Agency: Honigman Miller Schwartz and Cohn LLP
- Agent Lucy X. Yang; Jonathan P. O'Brien
- Main IPC: A61K31/517
- IPC: A61K31/517 ; C07D239/84 ; C07D471/04 ; C07D239/94 ; C07D401/12 ; C07D401/14 ; C07D403/04 ; C07D239/42

Abstract:
The present invention provides compounds of Formula I that modulate PI3 kinase activity and methods of treatment of diseases and conditions associated with PI3 kinase activity.
Public/Granted literature
- US20150141442A1 CHEMICAL ENTITIES AND THERAPEUTIC USES THEREOF Public/Granted day:2015-05-21
Information query
IPC分类: